Home >> Healthcare >> Food & Beverage >>

Global Secondary Progressive Multiple Sclerosis Drug Market Data Survey Report 2013-2025

Published: Mar-2019 | Format: PDF | HeyReport | Number of pages: 82 | Code: MRS - 414625

Summary
The global Secondary Progressive Multiple Sclerosis Drug market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
    AB Science SA 
    Actelion Ltd 
    Biogen, Inc. 
    F. Hoffmann-La Roche Ltd. 
    Genzyme Corporation 
    Glialogix, Inc. 
    Immune Response BioPharma, Inc. 
    Innate Immunotherapeutics Ltd 
    Kyorin Pharmaceutical Co., Ltd. 
    Mallinckrodt Plc 
    MedDay SA 
    MedImmune, LLC 
    Merck KGaA 
    Meta-IQ ApS 
    Novartis AG 
    Opexa Therapeutics, Inc. 
    Xenetic Biosciences (UK) Limited
Major applications as follows:
    Hospital 
    Clinic 
    Others
Major Type as follows:
    Inebilizumab 
    GLX-1112 
    DC-TAB 
    Etomoxir 
    IB-MS 
    Others
Regional market size, production data and export & import:
    Asia-Pacific
    North America
    Europe
    South America
    Middle East & Africa
Table of Contents
1 Global Market Overview
    1.1 Scope of Statistics
        1.1.1 Scope of Products
        1.1.2 Scope of Manufacturers
        1.1.3 Scope of Application
        1.1.4 Scope of Type
        1.1.5 Scope of Regions/Countries
    1.2 Global Market Size
2 Regional Market
    2.1 Regional Production
    2.2 Regional Demand
    2.3 Regional Trade
3 Key Manufacturers
    3.1 AB Science SA 
        3.1.1 Company Information
        3.1.2 Product & Services
        3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.1.4 Recent Development
    3.2 Actelion Ltd 
        3.2.1 Company Information
        3.2.2 Product & Services
        3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.2.4 Recent Development
    3.3 Biogen, Inc. 
        3.3.1 Company Information
        3.3.2 Product & Services
        3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.3.4 Recent Development
    3.4 F. Hoffmann-La Roche Ltd. 
        3.4.1 Company Information
        3.4.2 Product & Services
        3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.4.4 Recent Development
    3.5 Genzyme Corporation 
        3.5.1 Company Information
        3.5.2 Product & Services
        3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.5.4 Recent Development
    3.6 Glialogix, Inc. 
        3.6.1 Company Information
        3.6.2 Product & Services
        3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.6.4 Recent Development
    3.7 Immune Response BioPharma, Inc. 
        3.7.1 Company Information
        3.7.2 Product & Services
        3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.7.4 Recent Development
    3.8 Innate Immunotherapeutics Ltd 
        3.8.1 Company Information
        3.8.2 Product & Services
        3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.8.4 Recent Development
    3.9 Kyorin Pharmaceutical Co., Ltd. 
        3.9.1 Company Information
        3.9.2 Product & Services
        3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.9.4 Recent Development
    3.10 Mallinckrodt Plc 
        3.10.1 Company Information
        3.10.2 Product & Services
        3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.10.4 Recent Development
    3.11 MedDay SA 
        3.11.1 Company Information
        3.11.2 Product & Services
        3.11.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.11.4 Recent Development
    3.12 MedImmune, LLC 
        3.12.1 Company Information
        3.12.2 Product & Services
        3.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.12.4 Recent Development
    3.13 Merck KGaA 
        3.13.1 Company Information
        3.13.2 Product & Services
        3.13.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.13.4 Recent Development
    3.14 Meta-IQ ApS 
        3.14.1 Company Information
        3.14.2 Product & Services
        3.14.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.14.4 Recent Development
    3.15 Novartis AG 
        3.15.1 Company Information
        3.15.2 Product & Services
        3.15.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.15.4 Recent Development
    3.16 Opexa Therapeutics, Inc. 
        3.16.1 Company Information
        3.16.2 Product & Services
        3.16.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    3.17 Xenetic Biosciences (UK) Limited
        3.17.1 Company Information
        3.17.2 Product & Services
        3.17.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
    4.1 Hospital 
        4.1.1 Overview
        4.1.2 Hospital  Market Size and Forecast
    4.2 Clinic 
        4.2.1 Overview
        4.2.2 Clinic  Market Size and Forecast
    4.3 Others
        4.3.1 Overview
        4.3.2 Others Market Size and Forecast
5 Market by Type
    5.By Inebilizumab 
    5.1 Inebilizumab 
        5.1.1 Overview
        5.1.2 Inebilizumab  Market Size and Forecast
    5.2 GLX-1112 
        5.2.1 Overview
        5.2.2 GLX-1112  Market Size and Forecast
    5.3 DC-TAB 
        5.3.1 Overview
        5.3.2 DC-TAB  Market Size and Forecast
    5.4 Etomoxir 
        5.4.1 Overview
        5.4.2 Etomoxir  Market Size and Forecast
    5.5 IB-MS 
        5.5.1 Overview
        5.5.2 IB-MS  Market Size and Forecast
    5.6 Others
        5.6.1 Overview
        5.6.2 Others Market Size and Forecast
6 Price Overview
    6.1 Price by Manufacturers
    6.2 Price by Application
    6.3 Price by Type
7 Conclusion

                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)1500 View Pricing